Search | Page 31 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clofarabine in the treatment of myelodysplastic syndromes

    ... patients with MDS and acute myeloid leukemia (AML).  Early research studies identified 40 mg/m2 daily for 5 days per course as the ... cell transplantation in patients with MDS. Additional clinical trials are needed to define which patients derive the most benefit ...

    Research Review last updated 05/02/2016 - 9:18am.

  2. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... or > than or = to 2nd remission ALL/CLL in 1st remission clinical or molecular features indicating a high risk for relapse; or ALL/CLL > ... ) Each patient must be willing to participate as a research subject and must sign an informed consent form.   Donor ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  3. Hideki Makishima, MD, PhD

    ... Dr. Makishima is a current AA&MDSIF Research grant awardee at Taussig Cancer Institute, Cleveland Clinic, working ... of the mutations that contribute to disease presentation and clinical course. He is the Principal Investigator on a project (Clonal ...

    Bio last updated 03/11/2016 - 1:41pm.

  4. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  The aim of this research is to look at two conditions, Essential Thrombocythemia (ET) and ...

    Clinical Trial last updated 04/29/2016 - 9:59am.

  5. Myelodysplastic syndromes: What do hospitalists need to know?

    ... mechanisms that contribute and are the subject of current research.  The disease varies greatly from patient to patient.  There are ... from supportive care to possible enrollment in clinical trials.  In addition to supportive care, lower-risk patients are ...

    Research Review last updated 05/02/2016 - 9:21am.

  6. Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  This research study uses special blood cells called multiple tumor-associated ...

    Clinical Trial last updated 04/28/2016 - 11:40am.

  7. A Study of PLX51107 in Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... Purpose:  The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics, and ...

    Clinical Trial last updated 04/27/2016 - 2:09pm.

  8. Phoenix Ho, MD

    ... Title:  Acting Assistant Professor and Research Associate Institution:  ... for children with bone marrow failure and leukemia.  His clinical interests include the treatment of inherited bone marrow failure ...

    Bio last updated 03/11/2016 - 1:41pm.

  9. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    For more details on this clinical trial, including contact information, please see this trial’s ... appropriate supportive care , follow-up, and research tests Intervention:  ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  10. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s ... appropriate supportive care , follow-up, and research tests Haploidentical Donor Exclusion Criteria: ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.